Please login to the form below

Not currently logged in
Email:
Password:

outcomes

This page shows the latest outcomes news and features for those working in and with pharma, biotech and healthcare.

Roche builds on Immunocore ImmTAC deal

Roche builds on Immunocore ImmTAC deal

The outcome of that initial partnership was to develop a number of novel cancer candidates by using Immunocore’s TCR technology known as ImmTAC (Immune Mobilising Monoclonal TCRs Against Cancer) molecules.

Latest news

More from news
Approximately 12 fully matching, plus 1,107 partially matching documents found.

Latest Intelligence

  • Behaviour change – a missing ingredient? Behaviour change – a missing ingredient?

    This showed that designing a campaign with clear behavioural targets and fundamental psychological theory can result in impressive outcomes in an area of health that is notoriously difficult to influence.

  • Behaviour change: what is the buzz all about? Behaviour change: what is the buzz all about?

    The increasing pressure to demonstrate true value has – quite rightly – led to a greater need to justify investment in communications in terms of the impact it has on predefined outcomes. ... outcomes and, in doing so, demonstrate the real value of

  • Three steps forward, four steps back Three steps forward, four steps back

    A better outcome can only result from a change in patient behaviour, ie adherence to a therapeutic pathway. ... In the end, however, the best outcomes arise when the data is interpreted by people – nurses, consultants, carers and the patients themselves

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    Do not rely on biomarkers (such as pathological forms of α-Synuclein), but put clinical outcomes as an endpoint in phase 2 trials. ... Today, innovative, digital endpoints make it much easier to reliably assess motor function as a clinical outcome, also

  • Nudge-nudge, think-think Nudge-nudge, think-think

    The power of achieving the triad of capability, opportunity and peer endorsement is evidenced by a recent study into how to avoid retrograde outcomes when switching patients from biologics to biosimilars. ... There’s a huge focus – across the

More from intelligence
Approximately 10 fully matching, plus 362 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 505 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics